Translational Neuroscience Center (TNC)
The goal of this Center is to provide an infrastructure to assist researchers in preclinical and clinical studies
to develop new diagnostics and treatments for neurological diseases. The TNC is comprised of four units.
• Drug Development Unit, directed by Dr. Joseph Steiner
The Drug Development Unit provides assistance with development of throughput assays for identified targets
for drug development using primary brain cells or stem cell derived neuronal and glial cells.
• Neurodifferentiation Unit, directed by Dr. David Wang
The Neurodifferentiation Unit delineates new techniques for converting blood derived stem cells into neurons to
develop personalized medicine and study disease pathogenesis.
• Clinical Proteomics Unit, directed by Dr. Jeffrey Kowalak
The Clinical Proteomics Unit uses state-of-the-art mass spectroscopy based techniques to dicipher the proteome
in the cerebrospinal fluid and other biological materials.
For additional information about the TNC contact: ClinicalDirector@ninds.nih.gov.